Jonathan Irish
-
New screening method could pave the way for future cancer drug discoveries
The laboratories of Brian Bachmann and Jonathan Irish have developed a method to discover new small molecules that may kill cancer cells by working through the body’s immune system. Read MoreJan 17, 2023
-
Artificial intelligence offers a chance to optimize COVID-19 treatment in international partnership
Jonathan Irish joins an international collaboration by deploying artificial intelligence to optimize COVID-19 treatment and vaccine development. Read MoreMay 29, 2020
-
Deep Healing: Two alumni are making waves in drug discovery by plumbing the oceans’ depths for new therapeutic molecules
Sirenas, a San Diego-based company founded by Vanderbilt alumni Eduardo Esquenazi, BS'98, and Jake Beverage, BA'98, is applying trailblazing methods toward drug discovery. Read MoreSep 6, 2018
-
Looking beyond the ‘magic bullet’ approach to drug discovery
Vanderbilt scientists have developed a new process that can rapidly and inexpensively identify personalized cancer drugs derived from nature. Read MoreMay 1, 2018
-
Investigators seek new way to define cell identity
Vanderbilt researchers hope their new method to describe cells will be widely adopted and used to generate a “Who’s Who” database of cell types. Read MoreMar 2, 2017
-
Single-cell analysis of solid tumors
A new method will make it possible to study solid tumors and healthy tissues using mass cytometry. Read MoreDec 12, 2016